I. Kovalev, D. Sadykova, I. V. Leontieva, E. Slastnikova, Ch. D. Khaliullina, I. N. Zakharova, I. Trunina, L. Mozzhukhina, O. V. Kiselnikova, O. Y. Khalidullina, S. Ushakova, G. Santalova
tlooto Summary
In the Russian Federation, until now, measurement of cholesterol levels has not been included in any examination of a child as part of dispensary monitoring, but the new resolution pays special attention to children from risk groups and the measurement of total cholesterol from capillary blood at the ages of 6 and 10 years.
Abstract
Cardiovascular diseases are one of the most common causes of disability and mortality in the young working age population worldwide. Atherosclerosis is a key pathological process that leads to early cardiovascular catastrophes, including heart attacks, strokes and ischemic heart disease. Timely diagnosis of dyslipidemia can ensure the initiation of effective treatment and prevention. Hereditary forms of lipid metabolism disorders are particularly dangerous and require close attention, starting from childhood. One of the effective methods for diagnosing dyslipidemia is screening of blood cholesterol levels. The world practice includes several types of screening, but the most commonly used are selective and universal. In the Russian Federation, until now, measurement of cholesterol levels has not been included in any examination of a child as part of dispensary monitoring. The new resolution pays special attention to children from risk groups and the measurement of total cholesterol from capillary blood at the ages of 6 and 10 years.
Citation format
KOVALEV, I., et al. Management of the dyslipidemia in children and adolescents. Rossiyskiy Vestnik Perinatologii i Pediatrii, 2026, 71(1): 118–124.